Meeting Opportunity, Presented by MIT Startup Exchange & MIT Koch Institute
Cracking cancer is among the most ambitious goals of contemporary medicine. We have never been closer. A tremendous amount of innovation is ongoing. MIT Startup Exchange is convening an annual innovation event to discuss the latest advances in cancer innovation from the perspective of industry, academia, venture, and startups in the MIT ecosystem redefining the field today. We aim to cover innovation models, technologies, collaboration patterns, and partnerships and will take a close look at the leading edge trends in genomics, personalized medicine, immunotherapy, CRISPR , Artificial Intelligence, nano medicine, knowledge discovery, analytics, and more.
Join the MIT Startup Exchange, MIT Industrial Liaison Program, MIT faculty, MIT-connected startups, investors, and corporate innovators on Thursday, Dec 7, 2017, to explore how synthetic technology is shaping society, business, and life as we know it. The target audience is the MIT innovation ecosystem, including faculty, students, startups, and ILP member companies. We have reserved 10 seats for MIT-connected startup founders who can apply for a Lightning Talk. This event should attract startups from the following clusters/areas: biotech, advanced manufacturing, nanotech & new materials, healthcare, ICT, sensors, AI, foodtech and beyond.